BM
AZN icon

Bridger Management’s AstraZeneca AZN Stock Holding History

Bridger Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-78,200
Closed -$8.58M – 26
2022
Q3 		$8.58M Sell
78,200
-110,100
-58% -$14M 2.6% 15
2022
Q2 		$24.9M Buy
+188,300
New +$24.7M 5.61% 5

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridger Management's AZN Position: Q4 2022 in Review

Bridger Management sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 78,200 shares — an estimated $8.58M sold.

Bridger Management first reported a position in AZN in Q2 2022 and held it in 2 quarters. The position peaked at $24.9M in Q2 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Bridger Management reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
  • Bridger Management sold 78,200 AstraZeneca shares in Q4 2022, an estimated $8.58M.
  • Bridger Management first reported a position in AstraZeneca in Q2 2022 and held it in 2 quarters.
  • Bridger Management's AstraZeneca position peaked at $24.9M in Q2 2022.
  • 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Bridger Management's 13F filing for Q4 2022, filed 15 Feb 2023.